Home
  2010.09.03.Fir.
E-Journal
Online Submissions
Feed Back
Papers With
a High
Impact Factor
Links
Visiting Times:
    
Visiting Times
  of Today:
      
 Now Online:
      
 
Notice from Thomson/ISI 2006-07-14: World Journal of Gastroenterology has been re-accepted for coverage in Current Contents/Clinical Medicine and SCIE.
 HTML      PDF

Goncalves LL, Farias A, Goncalves PL, D'Amico EA, Carrilho FJ.Branch retinal vein thrombosis and visual loss probably associated with pegylated interferon therapy of chronic hepatitis C.
World J Gastroenterol 2006 July;12(28):4602-4603

Branch retinal vein thrombosis and visual loss probably associated with pegylated interferon therapy of chronic hepatitis C

Goncalves LL, Farias A, Goncalves PL, D'Amico EA, Carrilho FJ.

Rua Inacio Higino 198/201, Vila Velha, ES, 29101-430, Brazil. lucianalofego@terra.com.br

Ophthalmological complications with interferon therapy are usually mild and reversible, not requiring the withdrawal of the treatment. We report a case of a patient who had visual loss probably associated with interferon therapy. Chronic hepatitis C virus infection (genotype 1a) was diagnosed in a 33-year old asymptomatic man. His past medical history was unremarkable and previous routine ophthalmologic check-up was normal. Pegylated interferon alpha and ribavirin were started. Three weeks later he reported painless reduction of vision. Ophthalmologic examination showed extensive intraretinal hemorrhages and cotton-wool spots, associated with inferior branch retinal vein thrombosis. Antiviral therapy was immediately discontinued, but one year later he persists with severely decreased visual acuity. This case illustrates the possibility of unpredictable and severe complications during pegylated interferon therapy.
 


The WJG Press, Room 1066, Yishou Garden ,
No. 58, North Langxinzhuang Road,
PO Box 2345, Beijing 100023, China
Fax: +86-10-85381893
Telephone: +86-10-85381892
E-mail: wjg@wjgnet.com
http: // www.wjgnet.com
Copyright 2004-2007 by The WJG Press and Beijing Baishideng BioMed Technology Co., Ltd.